FRIEDMAN PAUL A sold MDGL
July 16, 2025 · Form 4 insider transaction
FRIEDMAN PAUL A sold 5,784 shares of Madrigal Pharmaceuticals, Inc. at $355.61 per share, a transaction worth $2.06M. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
5,784
Price
$355.61
Total value
$2.06M
InsiderFRIEDMAN PAUL A
RoleDirector
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJuly 16, 2025
Filing dateJuly 18, 2025
Shares owned after188,364
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025.; The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $355.13 to $356.11, inclusive.